NCT01286896 2025-07-10
Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors
The Netherlands Cancer Institute
Phase 1 Completed
Clinical Trials
8 trialsNCT06940349 2025-04-23
COPS-01
Rabin Medical Center
Phase 1/2 Recruiting
NCT02450123 2022-06-15
Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors
Samsung Medical Center
Phase NA Completed
NCT02058901 2019-07-17
Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.
Amsterdam UMC, location VUmc
Phase 1 Completed
NCT00884676 2015-10-09
Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors
University of Miami
Phase 1 Completed
NCT00720148 2014-08-26
A Phase I Trial of Bortezomib and Sunitinib
Emory University
Phase 1 Completed
NCT00583063 2013-06-12
Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers
University of Chicago
Phase EARLY_PHASE1 Completed
NCT00495872 2012-10-18
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
M.D. Anderson Cancer Center
Phase 1 Completed